Navigation Links
Stem Cell Research - Changing Wishes to Possibilities and Possibilities to Reality

The first International symposium on Stem cell Research and Therapy was conducted in Chennai, on the 6th of January. The programme was organized by LifeCell//, a pioneer in stem cell banking in association with Sri Ramachandra Medical College and Research Institute, one of the reputed medical institutions in the country.

Dr. Mammen Chandy, a leading hematologist, CMC, Vellore, headed the symposium. Following a small introduction about ‘Journey of LifeCell’, the scientific session was held. Dr. Paul. R. Sanberg, Dr. Umesh Banakar, Dr.Michael E.Trigg, Dr. Naynesh Kamani were amongst the participants.

Different aspects related to the potential of stem cell therapy and research was discussed in detail. The results of ‘Stem cell therapy in the treatment of neurological disorders such as ALS and stroke’ (in animal models), the ‘Role of stem cell transplantation in hematological malignancies’ (chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), aplastic anemia, Hodgkin’s disease), an ‘Overview of the ethical concerns associated with human stem cell research’, the possibility of ‘Stem cell transplantation as a curative therapy: Examples of Cord Blood use in Children- Outcome and Complications’ and the use of ‘Cord blood as an alternative source of haematopoietic Stem Cells for Transplantation in Children’ were some of the topics discussed.

The ultimate goal of stem cell research is to repair a damaged tissue that cannot heal by itself. Stem cells that are rightly termed as the ‘proverbial nectar of immortality’, can be used in the treatment of many diseases, which are often thought incurable. A few areas where this new treatment modality can be applied range from chronic diseases such as diabetes, stroke, cardiovascular disease to acute conditions like traumatic brain injury and limb amputation.

Stem cell therapy and research has drawn much exc
'"/>




Page: 1 2

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
(Date:5/22/2008)..., N.C. -- A new study by Duke University researche...O) system in the life of a cell plays a key role i...ve treatment of illnesses such as heart disease an...a major biological signaling pathway that has been...s, and it is linked to cancer and other diseases w...
(Date:5/22/2008)...entation Will be Webcast Live and Archived on Comp...-FirstCall/ -- Vanda Pharmaceuticals,Inc. (Nasdaq:...he development,and commercialization of clinical-s... disorders, today announced that Mihael H. Polymer...r a corporate presentation on,Wednesday, May 28, 2...
(Date:5/22/2008)... BEACH, Calif., May 22 /PRNewswire/ -- Whether you... short getaway, if you are an older adult,there ar...re a healthy,trip. According to Timothy Schwab, M....se ten tips for seniors apply whether you,re plann...s away., 1. Discuss travel plans with your ...
(Date:5/22/2008)...udy suggests threat of starvation triggers the swi...) -- New animal research suggests the body,s biolo... the rise and fall of the sun, can be overridden i..., The finding is based on work with mice and ha...cations are that, when faced with starvation, the ...
Breaking Medicine News(10 mins):Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 2Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 3Health News:Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference 2Health News:SCAN Health Plan Offers Seniors Ten Tips for Safe and Healthy Travel 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 3Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 4
...oral treatment for smoking, called Zyban. The pil...y the first product aimed at stopping smoking and ...wspersons, Mr. Kalyanasundaram, Director (Pharmace...ete treatment osts about Rs. 5000 and takes about ...
... of cancer, is avenged now by the new proven effec...dermal growth factor receptor tyrosine kinase inhi... in patients with advanced non-small cell lung can...ation with standard chemotherapy agents after segm...
...ls of S-nitrosoalbumin, a naturally occuring chemi...ngerous complication of pregnancy affects 10% of a...en into a life threatening condition called Eclamp...ng pregnancy. The research was led by Dr.Valerian...
... embarking on an exercise to grade hospital and me.... Sanjiv Malik, Honorary Secretary-General of the ...nce with ORGMARG to create a database on all the m...it allopathy or homeopathy, he said. The process ...
Other Medicine News:
(Date:5/22/2008)...didate, RDEA806, Demonstrated No Reproductive Toxi... -, - RDEA427 Selected as Clinical Candidate, Demo...ential for Once Daily Oral Dosing -, SAN DIEGO, M... Inc.,(Nasdaq: RDEA ) today announced preclinical...tase inhibitor (NNRTI) candidate, RDEA806, demonst...
(Date:5/21/2008)...derscore the Utility of CAPHOSOL in Treating Oral ...- New data show that CAPHOSOL(R), (http://www.caph...eves painful oral,mucositis (OM) and improves qual...erapy and radiation therapy. These data were repor... 33rd Annual Congress of the,Oncology Nursing Soci...
(Date:5/21/2008)...nted at 12th World Congress on the Menopause show ...yspareunia, two of the most frequent s... ARBOR, Mich., May 21 /- QuatRx Pharm...rom a pivotal Phase 3 study of Ophena(TM),(ospemif...mptoms of,vulvovaginal atrophy, a common condition...
(Date:5/21/2008)...EIGHTS, N.J., May 21 /- Gen...ed that multiple abstracts,featuring its lead onco...meeting of the American Society of Clinical Oncolo...he abstracts include the following:, -- Initial ... G4544, an oral gallium-containing Compound. ...
Breaking Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 2CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 3CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 5CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 6QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 1QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 3Hookah Smoking as Tough on Lungs as Cigarettes 9019 1Hookah Smoking as Tough on Lungs as Cigarettes 9019 2Hookah Smoking as Tough on Lungs as Cigarettes 9019 3Novel anticancer strategy moves from laboratory to clinic 9014 1Novel anticancer strategy moves from laboratory to clinic 9014 2Novel anticancer strategy moves from laboratory to clinic 9014 3
ORTHOSET Radiopaque Bone Cement consists of a two component system: a sterile,ampule containing bone cement liquid within a blister pack, and a sterile polyethylene bag,containing bone cement pow
Low viscosity bone cement without antibiotics for syringe use with an average setting time of approx. 7-9 Min., 40g of powder and 14.6g of liquid.
...eoscope represents new thinking to address common ... eliminating a 5.85 mm diameter outer arthroscope ...diameter Videoscope has superior access and mobili...and especially in the elbow and ankle. In conjunct...
... llifestly of hypertensive and hopotensive patient...sociated with blood pressure monitoring conducted ...ep instrument, it enables physicians to conduct ro...f ther patient's homes. With its built-in proprie...
Medicine Products: